Projects / Programmes source: ARIS

Primerjava vpliva interferona beta-1a in interferona beta-1b na biološke markerje multiple skleroze (Slovene)

Edit
Research activity

Code Science Field Subfield
3.03.00  Medical sciences  Neurobiology   

Code Science Field
B640  Biomedical sciences  Neurology, neuropsychology, neurophysiology 
Keywords
multiple sclerosis, interferon beta, cytokines, adhesion molecules
Evaluation (metodology)
source: COBISS
Evaluation of bibliographic research performance indicators according to ARIS methodology
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Organisations (1) , Researchers (6)
0312  University Medical Centre Ljubljana
no. Code Name and surname Research area Role Period No. of publications
1.  17692  Franci Benko    Researcher  2000 - 2002  0 
2.  01974  PhD Anton Grad  Cardiovascular system  Researcher  2000 - 2002  290 
3.  14075  PhD Alenka Horvat Ledinek  Neurobiology  Researcher  2000 - 2002  148 
4.  05341  MSc Mojca Kambič-Budkovič  Neurobiology  Researcher  2000 - 2002  26 
5.  05298  PhD Anton Mesec  Neurobiology  Head  2000 - 2002  152 
6.  08752  PhD Saša Šega Jazbec  Cardiovascular system  Researcher  2000 - 2002  204 
Abstract
Controlled clinical trials in relapsing-remitting multiple sclerosis have established that interferon beta-1a and interferon beta1-b are effective in reducing the frequency of relapses, the number of demyelinated plaques and the progression towards disability. The aim of this project is to compare effectiveness of both interferons by studying biological markers of disease. We will compare the influence of interferon beta-1a and interferon beta-1b on cytokines (interferon gamma, IL-6, IL-10, IL-12) and adhesion molecules (sVCAM-1, VLA-4).
Confirmation required
Views history
Favourite